Skip to main content
logo
Delta-Fly Pharma, Inc. (TYO:4598)
Japan flag Japan · Delayed Price · Currency is JPY
99.00
-1.00 (-1.00%)
Oct 9, 2026, 3:30 PM JST

Delta-Fly Pharma Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
-----300
Revenue Growth
-----0%
Gross Profit
-----300
Operating Income
-1,667-1,605-1,708-1,403-1,315-961
Net Income
-1,680-1,625-1,721-1,429-1,328-967
Earnings Per Share
-134.57-140.37-195.56-198.72-234.37-178.52
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
831453381,4178441,268
Total Debt
------
Net Cash (Debt)
831453381,4178441,268
Net Cash Growth
-88.63%-57.10%-76.15%67.89%-33.44%-39.27%
Net Cash Per Share
6.6512.5338.41197.05148.95234.09

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--1,557-1,834-1,279-1,303-940
Capital Expenditures
----1--
Free Cash Flow
--1,557-1,834-1,280-1,303-940
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
-----100.00%
Operating Margin
------320.33%
Pretax Margin
------321.33%
Profit Margin
------322.33%
FCF Margin
------313.33%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
-----23.12